Maksillada Tekrarlayan Santral Dev Hücreli Granülomun Alternatif Tedavi Yöntemi: Yedi Yıllık Vaka Raporu

Amaç: Nadir görülen bu vakada amaç, agresif santral dev hücreli granulomun (SDHG) cerrahi eksizyon ve kortikosteroid enjeksiyonu tekniğiyle tedavisinin uzun dönem bulgularını bildirmektir. SDHG, maksilla ve mandibulada ender rastlanan kemiğin iyi huylu lezyonudur. Yöntem: 14 yaşında bayan hasta sol ön bölgede maksillada vestibül korteksteki şişlik nedeniyle kliniğimize başvurdu. Lezyon cerrahi olarak lokal anestezi altında çıkarıldı. Histolojik tanısı SDHG olarak kondu. Takip eden sürede iyileşme olmadı. Sekiz ay sonra aynı saha tekrar açılarak derin küretaj yapıldı. Aynı seansta lezyonlu bölgeye kortikosteroid enjeksiyonu yapıldı. Enjeksiyon takip eden 6 hafta boyunca haftada bir kez olmak üzere tekrarlandı. Bulgular: Takip eden yedi yıllık takipte lezyon ve sol maksiller kanin stabil ve asemptomatik idi. Lezyon ile ilgili bri tekrarlama görülmedi. Sonuç: Cerrahi küretajın lezyon içine kortikosteroid enjeksiyonu ile kombinasyonu SDHG tedavisi için umut verici bir yöntem olarak tekrarlayan lezyonlarda önerilebilir

Alternative Treatment Modality Of Recurrent Central Giant Cell Granuloma In The Maxilla: Seven Year Follow Up Case Report

Objectives: The aim of this unique report was to evaluate the long term outcome of an aggressive central giant cell granuloma (CGCG) lesion by using surgical removal and corticosteroid injection technique.CGCG is an uncommon benign bony lesion that occurs in the mandible and maxilla. Methods: A 14 year-old female was admitted to our clinic with a complaint of hard swelling in the left maxillary anterior vestibule cortex. The lesion was surgically removed by enucleation which was carried out under local anesthesia. Histological investigation revealed a diagnosis of central giant cell granuloma. Patient’s recovery was uneventful. During follow-up for eight months, the mass was opened and deep curettage was performed. After that, at same séance, corticosteroids was injected. The injection was repeated at the same rate once a week for 6 following weeks. Results: At the follow-up examination after seven years, lesion and left maxillary canine were stable and asymptomatic. There was no recurrence of lesion. Conclusion: Surgical removal combined with intralesional corticosteroid injection is a promising treatment approach for CGCG, and it can be suggested to reduce the recurrence of the lesion

___

  • 1. Tosco P, Tanteri G, Iaquinta C, Fasolis M, Roccia F, Sid Berrone, Garzino-Demo P. Surgical treatment and reconstruction for central giant cell granuloma of the jaws: A review of 18 cases. J Cranio-Maxillofac Surg 2009;37:380-387.
  • 2. Kruse-Lösler B, Diallo R, Gaertner C, Mischke K, Joos U, Kleinheinz J. Central giant cell granuloma of the jaws: A clinical, radiologic, and histopathologic study of 26 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:346-354.
  • 3. Carlos R, Sedano HO. Intralesional corticosteroids as an alternative treatment for central giant cell granuloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:161-166.
  • 4. Lange J, Akker HP, Berg H. Central giant cell granuloma of the jaw: A review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:603-15.
  • 5. Gunel C, Erpek G, Meteoglu I. Giant cell reparative granuloma in the hard palate. Int J Pediatr Otorhinolaryngol Extra 2007;2:76-79.
  • 6. Nogueira RLM, Teixeira RC, Cavalcante RB, Ribeiro RA, Rabenhosrt SHB. Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant-cell granuloma in 21 cases. Int J Oral Maxillofac Surg 2010.doi:10.1016/j.ijom.2010.06.015. pg:1-7.
  • 7. Stavropoulos F, Katz J. Central giant cell granulomas: A systematic review of the radiographic characteristics with the addition of 20 new cases. Dentomaxillofac Radiol (2002) 31, 213 -217.
  • 8. Whitaker SB, Waldron CA. Central giant cell lesions of the jaws. A clinical, radiologic, and histopathologic study. Oral Surg Oral Med Oral Pathol 1993;75:199-208.
  • 9. Pontes FSC, Fonseca FP, Souza de Jesus A, Alves A C G, Araujo L M, Silva Do Nascimento L, Pontes HAR. Nonendodontic lesions misdiagnosed as apical periodontitis lesions: Series of case reports and review of literature. J Endod 2014;40:16-27.
  • 10. Nair PNR, Pajoarola G, Schroeder HE. Types and incidence of human periapical lesions obtained with extracted teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:93-102.
  • 11. Farrier SL, Farrier JN, Smart MK, Nash ES. A 10-year review of the occurence and treatment of central giant cell granulomas, in a District General Hospital. J Oral Pathol Med 2006;35:332-337.
  • 12. Motamedi MHK, Eshghyar N, Jafari SM, Lassemi E, Navi F, Abbas FM, Khalifeh S, Eshkevari PS. Peripheral and central giant cell granulomas of the jaws : A demographic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:e39-e43.
  • 13. Adornato MC, Paticoff K. Intralesional corticosteroid injection for treatment of central giant-cell granuloma. J Am Dent Assoc 2001:132:186-190.
  • 14. Terry BC, Jacoway JR. Management of central giant cell lesions: an alternative to surgical therapy. Oral Maxillofac Surg Clin N Am 1994;6:579-601.
  • 15. Khafif A, Krempl G, Medina JE. Treatment of giant cell granuloma of the maxilla with intralesional injection of steroids. Head Neck 2000; 22: 822–825.